PNC Financial Services Group’s Asterias Biotherapeutics Inc. Series A AST Stock Holding History

PNC Financial Services Group’s Portfolio AST Stock Details AST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-41	Closed	–	–	4407
2017 Q3	$0	Hold	41	–	–	﹤0.01%	4392
2017 Q2	$0	Hold	41	–	–	﹤0.01%	4351
2017 Q1	$0	Hold	41	–	–	﹤0.01%	4346
2016 Q4	$0	Hold	41	–	–	﹤0.01%	4249
2016 Q3	$0	Hold	41	–	–	﹤0.01%	4676
2016 Q2	$0	Hold	41	–	–	﹤0.01%	4723
2016 Q1	$0	Hold	41	–	–	﹤0.01%	4736
2015 Q4	$0	Hold	41	–	–	﹤0.01%	4802
2015 Q3	$0	Hold	41	–	–	﹤0.01%	4900
2015 Q2	$0	Hold	41	–	–	﹤0.01%	4925
2015 Q1	$0	Hold	41	–	–	﹤0.01%	4908
2014 Q4	$0	Buy	+41	New	+$165	﹤0.01%	4417

Other funds holding AST

Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NFC

Northeast Financial Consultants Westport, Connecticut $2.45B AUM 15.14% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Thrivent Financial for Lutherans Minneapolis, Minnesota $52.5B AUM 27.12% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

PNC Financial Services Group's AST Position: Q4 2017 in Review

PNC Financial Services Group sold out of Asterias Biotherapeutics Inc. Series A (AST) in Q4 2017, closing a stake of 41 shares.

PNC Financial Services Group first reported a position in AST in Q4 2014 and held it in 12 quarters. The position peaked at $0 in Q3 2017. 75 funds tracked by Wall St. Rank hold AST as of Q4 2017.

PNC Financial Services Group reported no remaining Asterias Biotherapeutics Inc. Series A position as of Q4 2017 after selling out during the quarter.
PNC Financial Services Group sold 41 Asterias Biotherapeutics Inc. Series A shares in Q4 2017.
PNC Financial Services Group first reported a position in Asterias Biotherapeutics Inc. Series A in Q4 2014 and held it in 12 quarters.
PNC Financial Services Group's Asterias Biotherapeutics Inc. Series A position peaked at $0 in Q3 2017.
75 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Series A as of Q4 2017.

Based on PNC Financial Services Group's 13F filing for Q4 2017, filed 9 Feb 2018.